Channelpedia

Cav3.1 Channel

499 automatically matched literature references

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

4

Yang W et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience, 2016 Jan 28 , 313 (213-24).

8

Raychaudhuri SK et al. KCa3.1(-/-) Mice Do Not Develop CIA: Regulatory Role for KCa3.1 in Autoimmune Arthritis.
J. Cell. Physiol., 2016 Feb 22 , ().

11

D'Alessandro G et al. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
Oncotarget, 2016 Apr 16 , ().

16

17

Goedicke-Fritz S et al. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells.
Eur. J. Cell Biol., 2015 Jul-Sep , 94 (391-400).

23

24

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

25

Harraz OF et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol., 2015 May , 145 (405-18).

30

Monteil A et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).

31

33

Elíes J et al. H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).

34

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

41

43

Huang C et al. KCa3.1: a new player in progressive kidney disease.
Curr. Opin. Nephrol. Hypertens., 2015 Jan , 24 (61-6).

45

Yu H et al. Noradrenaline upregulates T-type calcium channels in rat pinealocytes.
J. Physiol. (Lond.), 2015 Feb 15 , 593 (887-904).

51

Choi JY et al. Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts.
Biochem. Biophys. Res. Commun., 2015 Dec 25 , 468 (883-8).

58

Mesirca P et al. Functional role of voltage gated Ca(2+) channels in heart automaticity.
Front Physiol, 2015 , 6 (19).

59

Elíes J et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol., 2015 , 860 (353-60).

60

Duckles H et al. T-Type Ca(2+) Channel Regulation by CO: A Mechanism for Control of Cell Proliferation.
Adv. Exp. Med. Biol., 2015 , 860 (291-300).

63

65

Nakamura K et al. Proinflammatory Cytokines and Potassium Channels in the Kidney.
Mediators Inflamm., 2015 , 2015 (362768).

66

Calderón-Rivera A et al. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
PLoS ONE, 2015 , 10 (e0119134).

70

Cahalan SM et al. Piezo1 links mechanical forces to red blood cell volume.
Elife, 2015 , 4 ().

73

Harraz OF et al. Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.
Circ. Res., 2014 Sep 12 , 115 (650-61).

74

Chevalier M et al. T-type calcium channels are involved in hypoxic pulmonary hypertension.
Cardiovasc. Res., 2014 Sep 1 , 103 (597-606).

75

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

79

Huang C et al. Role of the potassium channel KCa3.1 in diabetic nephropathy.
Clin. Sci., 2014 Oct , 127 (423-33).

86

González-Ramírez R et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol., 2014 May , 229 (551-60).

87

Climent B et al. Effects of obesity on vascular potassium channels.
Curr Vasc Pharmacol, 2014 May , 12 (438-52).

88

Perissinotti PP et al. Down-regulation of endogenous KLHL1 decreases voltage-gated calcium current density.
Cell Calcium, 2014 May , 55 (269-80).

91

Panyi G et al. Ion channels and anti-cancer immunity.
Philos. Trans. R. Soc. Lond., B, Biol. Sci., 2014 Mar 19 , 369 (20130106).

94

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

99

100

Turner RW et al. T-type channels buddy up.
Pflugers Arch., 2014 Jan 11 , ().

102

Choi S et al. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease.
Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (81-9).

105

Michaela P et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).

109

Huang C et al. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Nephrol. Dial. Transplant., 2014 Feb , 29 (313-24).

112

Elíes J et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J., 2014 Dec , 28 (5376-87).

113

Lin H et al. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
Int. Immunopharmacol., 2014 Dec , 23 (642-8).

117

Zheng H et al. Expression and function of a T-type Ca2+ conductance in interstitial cells of Cajal of the murine small intestine.
Am. J. Physiol., Cell Physiol., 2014 Apr 1 , 306 (C705-13).

119

Carbone E et al. T-type channel-mediated neurotransmitter release.
Pflugers Arch., 2014 Apr , 466 (677-87).

120

Mesirca P et al. T-type channels in the sino-atrial and atrioventricular pacemaker mechanism.
Pflugers Arch., 2014 Apr , 466 (791-9).

121

Kuo IY et al. Role of T-type channels in vasomotor function: team player or chameleon?
Pflugers Arch., 2014 Apr , 466 (767-79).

123

Chemin J et al. Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch., 2014 Apr , 466 (689-700).

124

Shuba YM Models of calcium permeation through T-type channels.
Pflugers Arch., 2014 Apr , 466 (635-44).

130

Bladen C et al. Block of T-type calcium channels by protoxins I and II.
Mol Brain, 2014 , 7 (36).

137

Jenkins DP et al. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Assay Drug Dev Technol, 2013 Nov-Dec , 11 (551-60).

138

Hui K et al. Efficient experimental design and analysis of real-time PCR assays.
Channels (Austin), 2013 May-Jun , 7 (160-70).

139

140

Elies J et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).

147

Seo H et al. Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).

148

153

Stoneking CJ et al. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Am. J. Physiol., Cell Physiol., 2013 May 1 , 304 (C858-72).

155

Nosal OV et al. Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
Cell. Mol. Life Sci., 2013 May , 70 (1653-61).

163

Choi S et al. Contradictory Effects of Superoxide and Hydrogen Peroxide on KCa3.1 in Human Endothelial Cells.
Korean J. Physiol. Pharmacol., 2013 Jun , 17 (181-7).

164

Yu ZH et al. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Am. J. Respir. Cell Mol. Biol., 2013 Jun , 48 (685-93).

165

Sah R et al. Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 22 , ().

166

Harraz OF et al. Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
J. Cell. Sci., 2013 Jul 1 , 126 (2944-54).

167

Zhang Y et al. Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).

170

Cuddapah VA et al. Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3.
J. Neurosci., 2013 Jan 23 , 33 (1427-40).

171

Abd El-Rahman RR et al. Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jan 1 , 304 (H58-71).

176

Jang SJ et al. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Bioorg. Med. Chem. Lett., 2013 Dec 15 , 23 (6656-62).

180

Kelly MJ et al. Pacemaking Kisspeptin Neurons.
Exp. Physiol., 2013 Aug 30 , ().

184

Shan HQ et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).

186

Weisbrod D et al. SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells.
Proc. Natl. Acad. Sci. U.S.A., 2013 Apr 30 , 110 (E1685-94).

187

188

Choi S et al. NADPH oxidase 2-derived superoxide downregulates endothelial KCa3.1 in preeclampsia.
Free Radic. Biol. Med., 2013 Apr , 57 (10-21).

190

Hejl JL et al. P2X receptor stimulation amplifies complement-induced haemolysis.
Pflugers Arch., 2013 Apr , 465 (529-41).

191

D'Alessandro G et al. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
Cell Death Dis, 2013 , 4 (e773).

193

198

Sekiguchi F et al. T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci., 2013 , 122 (244-50).

201

Kobrinsky E et al. Selective fluorophore-assisted light inactivation of voltage-gated calcium channels.
Channels (Austin), 2012 May-Jun , 6 (154-6).

203

Lopez-Charcas O et al. Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol., 2012 Oct , 82 (658-67).

209

210

Balderas E et al. Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol., 2012 Jun , 227 (2542-55).

213

214

222

Yarotskyy V et al. Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.
J. Pharmacol. Exp. Ther., 2012 Feb , 340 (463-72).

229

Siwek M et al. Voltage-gated ca(2+) channel mediated ca(2+) influx in epileptogenesis.
Adv. Exp. Med. Biol., 2012 , 740 (1219-47).

231

Bodendiek SB et al. Triarylmethanes, a new class of cx50 inhibitors.
Front Pharmacol, 2012 , 3 (106).

242

Fang K et al. Mechanism of auxiliary β-subunit-mediated membrane targeting of L-type (Ca(V)1.2) channels.
J. Physiol. (Lond.), 2011 Sep 15 , 589 (4437-55).

246

Shao Z et al. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration.
Am. J. Respir. Cell Mol. Biol., 2011 Nov , 45 (962-8).

252

Pluteanu F et al. Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2011 Mar , 300 (C517-25).

253

257

258

Beckman-Sundh U et al. A screening method for phosphohistidine phosphatase 1 activity.
, 2011 Jun 17 , ().

259

265

Poulsen CB et al. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Kidney Int., 2011 Feb , 79 (443-51).

267

Liu G et al. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Beijing Da Xue Xue Bao, 2011 Dec 18 , 43 (804-8).

270

Lacinová L T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).

271

Astori S et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).

280

Waschk DE et al. Dual-color quantum dot detection of a heterotetrameric potassium channel (hKCa3.1).
Am. J. Physiol., Cell Physiol., 2011 Apr , 300 (C843-9).

281

Cieśla J et al. Phosphorylation of basic amino acid residues in proteins: important but easily missed.
Acta Biochim. Pol., 2011 , 58 (137-48).

283

Rotte A et al. Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion.
Cell. Physiol. Biochem., 2011 , 27 (597-604).

286

Cribbs L T-type calcium channel expression and function in the diseased heart.
Channels (Austin), 2010 Nov-Dec , 4 (447-52).

287

Cain SM et al. Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin), 2010 Nov-Dec , 4 (475-82).

288

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

289

Anderson D et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin), 2010 May-Jun , 4 (163-7).

291

294

Bailey MA et al. Characterization of the PCMBS-dependent modification of KCa3.1 channel gating.
J. Gen. Physiol., 2010 Oct , 136 (367-87).

298

Balut CM et al. ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes.
Am. J. Physiol., Cell Physiol., 2010 Nov , 299 (C1015-27).

299

300

302

Handforth A et al. T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.
Neuropharmacology, 2010 Nov , 59 (380-7).

305

Strege PR et al. T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).

306

Köhler R et al. Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.
Pflugers Arch., 2010 May , 459 (969-76).

309

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

310

Park YG et al. Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jun 8 , 107 (10731-6).

313

Oguri A et al. Involvement of CaV3.1 T-type calcium channels in cell proliferation in mouse preadipocytes.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1414-23).

314

Aromolaran KA et al. T-type current modulation by the actin-binding protein Kelch-like 1.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1353-62).

315

Kuo IY et al. Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
J. Cereb. Blood Flow Metab., 2010 Jun , 30 (1226-39).

316

Lee JE et al. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
Bioorg. Med. Chem. Lett., 2010 Jul 15 , 20 (4219-22).

318

Di L et al. Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jan 26 , 107 (1541-6).

320

Ono K et al. Cardiac T-type Ca(2+) channels in the heart.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (65-70).

321

Köhler R et al. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Expert Opin. Ther. Targets, 2010 Feb , 14 (143-55).

331

Pastukh V et al. Effect of hypernatremia on injury caused by energy deficiency: role of T-type Ca2+ channel.
Am. J. Physiol., Cell Physiol., 2010 Aug , 299 (C289-97).

337

Garneau L et al. Toward the Rational Design of Constitutively Active KCa3.1 Mutant Channels.
Meth. Enzymol., 2010 , 485 (437-57).

343

Cahalan MD et al. The functional network of ion channels in T lymphocytes.
Immunol. Rev., 2009 Sep , 231 (59-87).

345

Drígelová M et al. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
Can. J. Physiol. Pharmacol., 2009 Nov , 87 (923-32).

347

Walsh CP et al. Labelling of the 3D structure of the cardiac L-type voltage-gated calcium channel.
Channels (Austin), 2009 Nov , 3 (387-92).

348

Chen RS et al. A small peptide inhibitor of the low voltage-activated calcium channel Cav3.1.
Mol. Pharmacol., 2009 May , 75 (1042-51).

350

Harron SA et al. Volume regulation in the human airway epithelial cell line Calu-3.
Can. J. Physiol. Pharmacol., 2009 May , 87 (337-46).

356

Uebele VN et al. Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice.
J. Clin. Invest., 2009 Jun , 119 (1659-67).

360

Jensen LJ et al. Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?
Can. J. Physiol. Pharmacol., 2009 Jan , 87 (8-20).

365

Klein H et al. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.
Am. J. Physiol., Cell Physiol., 2009 Feb , 296 (C285-95).

368

Chantome A et al. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Exp. Cell Res., 2009 Dec 10 , 315 (3620-30).

372

Grgic I et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.
Proc. Natl. Acad. Sci. U.S.A., 2009 Aug 25 , 106 (14518-23).

373

Düfer M et al. Enhanced glucose tolerance by SK4 channel inhibition in pancreatic beta-cells.
Diabetes, 2009 Aug , 58 (1835-43).

377

Srivastava S et al. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Proc. Natl. Acad. Sci. U.S.A., 2008 Sep 23 , 105 (14442-6).

380

Alper SL Let's look at cysts from both sides now.
Kidney Int., 2008 Sep , 74 (699-702).

384

Trinh NT et al. EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair.
Am. J. Physiol. Lung Cell Mol. Physiol., 2008 Nov , 295 (L866-80).

388

Lauf PK et al. Apparent intermediate K conductance channel hyposmotic activation in human lens epithelial cells.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C820-32).

390

Nakamoto T et al. Apical maxi-K (KCa1.1) channels mediate K+ secretion by the mouse submandibular exocrine gland.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C810-9).

391

Chou CC et al. KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Expert Rev. Mol. Diagn., 2008 Mar , 8 (179-87).

392

393

Lounsbury KM Preventing stenosis by local inhibition of KCa3.1: a finger on the phenotypic switch.
Arterioscler. Thromb. Vasc. Biol., 2008 Jun , 28 (1036-8).

399

Obejero-Paz CA et al. Ni2+ block of CaV3.1 (alpha1G) T-type calcium channels.
J. Gen. Physiol., 2008 Aug , 132 (239-50).

401

Na HS et al. Attenuated neuropathic pain in Cav3.1 null mice.
Mol. Cells, 2008 Apr 30 , 25 (242-6).

402

Kurejová M et al. Monovalent currents through the T-type Cav3.1 channels and their block by Mg2+.
Gen. Physiol. Biophys., 2007 Sep , 26 (234-9).

406

Shepherd MC et al. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation.
Am. J. Respir. Cell Mol. Biol., 2007 Nov , 37 (525-31).

407

Tao R et al. Functional ion channels in mouse bone marrow mesenchymal stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1561-7).

413

416

Traboulsie A et al. Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).

418

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

419

Nicolaou SA et al. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
Am. J. Physiol., Cell Physiol., 2007 Apr , 292 (C1431-9).

420

Zhou C et al. Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2007 Apr , 292 (L833-44).

423

Deng XL et al. Properties of ion channels in rabbit mesenchymal stem cells from bone marrow.
Biochem. Biophys. Res. Commun., 2006 Sep 15 , 348 (301-9).

424

Nordskog BK et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience, 2006 Sep 1 , 141 (1365-73).

426

Qiu J et al. Estrogen upregulates T-type calcium channels in the hypothalamus and pituitary.
J. Neurosci., 2006 Oct 25 , 26 (11072-82).

428

439

Zhou C et al. T-type calcium channels in pulmonary vascular endothelium.
, 2006 Dec , 13 (645-56).

441

Perez-Reyes E et al. Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).

442

Lambert RC et al. Modulation of neuronal T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (611-27).

444

Perez-Reyes E Molecular characterization of T-type calcium channels.
Cell Calcium, 2006 Aug , 40 (89-96).

445

Vassort G et al. Role of T-type Ca2+ channels in the heart.
Cell Calcium, 2006 Aug , 40 (205-20).

446

Talavera K et al. Biophysics and structure-function relationship of T-type Ca2+ channels.
Cell Calcium, 2006 Aug , 40 (97-114).

447

Crunelli V et al. Thalamic T-type Ca2+ channels and NREM sleep.
Cell Calcium, 2006 Aug , 40 (175-90).

448

Lory P et al. T-type calcium channels in differentiation and proliferation.
Cell Calcium, 2006 Aug , 40 (135-46).

450

Srivastava S et al. Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.
Mol. Cell. Biol., 2006 Aug , 26 (5595-602).

452

Lacinova L et al. Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2+.
Acta Physiol (Oxf), 2006 Apr , 186 (249-60).

459

Marionneau C et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart.
J. Physiol. (Lond.), 2005 Jan 1 , 562 (223-34).

460

Yang SN et al. Beta-cell CaV channel regulation in physiology and pathophysiology.
Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).

462

Anderson MP et al. Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep.
Proc. Natl. Acad. Sci. U.S.A., 2005 Feb 1 , 102 (1743-8).

467

Banderali U et al. New insights on the voltage dependence of the KCa3.1 channel block by internal TBA.
J. Gen. Physiol., 2004 Oct , 124 (333-48).

469

Leresche N et al. Paradoxical potentiation of neuronal T-type Ca2+ current by ATP at resting membrane potential.
J. Neurosci., 2004 Jun 16 , 24 (5592-602).

470

Mudado MA et al. CaV 3.1 and CaV 3.3 account for T-type Ca2+ current in GH3 cells.
Braz. J. Med. Biol. Res., 2004 Jun , 37 (929-35).

472

473

476

477

Delisle BP et al. Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.
J. Membr. Biol., 2003 Jun 1 , 193 (185-94).

478

Talavera K et al. Pore structure influences gating properties of the T-type Ca2+ channel alpha1G.
J. Gen. Physiol., 2003 Jun , 121 (529-40).

480

481

Zhang YM et al. Characterization and regulation of T-type Ca2+ channels in embryonic stem cell-derived cardiomyocytes.
Am. J. Physiol. Heart Circ. Physiol., 2003 Dec , 285 (H2770-9).

482

Lee SC et al. Availability of low-threshold Ca2+ current in retinal ganglion cells.
J. Neurophysiol., 2003 Dec , 90 (3888-901).

483

Yunker AM et al. Low-voltage-activated ("T-Type") calcium channels in review.
J. Bioenerg. Biomembr., 2003 Dec , 35 (533-75).

484

Yunker AM Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
J. Bioenerg. Biomembr., 2003 Dec , 35 (577-98).

485

Gromová P et al. Inhibition of Cav3.1 channel by silver ions.
Gen. Physiol. Biophys., 2003 Dec , 22 (515-23).

490

Lacinová L et al. Gating of the expressed Cav3.1 calcium channel.
FEBS Lett., 2002 Nov 6 , 531 (235-40).

493

Sakata Y et al. Analysis of Ca(2+) currents in spermatocytes from mice lacking Ca(v)2.3 (alpha(1E)) Ca(2+) channel.
Biochem. Biophys. Res. Commun., 2001 Nov 9 , 288 (1032-6).

494

496

Ueki T et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Cancer Res., 2000 Apr 1 , 60 (1835-9).

499

Perez-Reyes E et al. Molecular characterization of two members of the T-type calcium channel family.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (131-43).